Coronavirus disease (COVID-19) technical guidance by WHO Infection prevention and control | страница 5
Infection prevention and control during health care when COVID-19 is suspected: interim guidance
John M Conly, Department of Medicine,
Microbiology, Immunology and Infectious
Diseases, Calvin, Phoebe and Joan Snyder Institute
for Chronic Diseases, Faculty of Medicine,
University of Calgary, Calgary, Canada.
Barry Cookson, Division of Infection and Immunity,
University College, London, United Kingdom.
Babacar N Doye, Board Member, Infection Control
Network, Dakar, Senegal.
Kathleen Dunn, Manager, Healthcare Associated
Infections and Infection Prevention and Control
Section, Centre for Communicable Disease
Prevention and Control, Public Health Agency of
Canada.
Dale Fisher, Global Outbreak Alert and Response
Network steering committee.
Fernanda Lessa, Epidemiologist, Division of
Healthcare Quality Promotion, Centers for Disease
Control and Prevention, Atlanta, USA.
Moi Lin Ling, Director, Infection Control
Department, Singapore General Hospital,
Singapore and President of Asia Pacific Society of
Infection Control (APSIC).
Fernando Otaiza O’Rayan, Head, National
IPC Program, Ministry of Health, Santiago, Chile
Diamantis Plachouras, Unit of Surveillance and
Response Support, European Centre for Disease
Prevention and Control.
Wing Hong Seto, Department of Community
Medicine, School of Public Health, University of
Hong Kong, Hong Kong, People’s Republic of
China.
Nandini Shetty, Consultant Microbiologist,
Reference Microbiology Services, Colindale,
Health Protection Agency, United Kingdom.
From WHO we also thank:
Benedetta Allegranzi, April Baller, Ana Paula Coutinho,
Janet Diaz, Christine Francis, Maria Clara Padoveze,
Joao Paulo de Toledo, Maria Van Kerkhove.
WHO continues to monitor the situation closely for any
changes that may affect this interim guidance. Should any
factors change, WHO will issue a further update. Otherwise,
this interim guidance document will expire 2 years after the
date of publication.
© World Health Organization 2020. Some rights reserved. This work is available under the CC BY-NC-
SA 3.0 IGO licence.
WHO reference number: WHO/2019-nCoV/IPC/2020.3
- 5-